Clinical trial
Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo
NCT00134368 · University of Medicine and Dentistry of New Jersey, Other · Completed
Key facts
| NCT number | NCT00134368 |
|---|---|
| Title | Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo |
| Official title | Pilot, Investigator-Initiated, Proof-of-Concept, Study of the Efficacy and Safety of Etanercept (Enbrel) in Adults With Vitiligo |
| Lead sponsor | University of Medicine and Dentistry of New Jersey, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Vitiligo |
| Intervention type | Drug |
| Interventions | Etanercept |
| Enrollment | 40 |
| Start date | Nov 1, 2003 |
| Completion | Dec 1, 2007 |
| First posted | Aug 24, 2005 |
| Last update posted | Aug 7, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: